Mycobacterium Avium Complex Clinical Trial
Official title:
Open, Noncomparative Trial of Multidrug Regimens Containing Azithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease
To determine the safety and efficacy of azithromycin, rifabutin and ethambutol given three times weekly in the treatment of lung infection with M. avium complex(MAC)
Azithromycin given 3 times weekly along with rifampin/rifabutin and ethambutol for treatment of MAC ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05192057 -
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
|
Phase 4 | |
| Withdrawn |
NCT01719042 -
Improving Tolerance of Treatment of Pulmonary MAC Infections
|
Phase 2 | |
| Completed |
NCT00600769 -
Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
|
Phase 4 | |
| Recruiting |
NCT03236987 -
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
|
Phase 3 | |
| Recruiting |
NCT04287049 -
A Study of Standard Drugs for Mycobacterium Avium Complex
|
Phase 2 | |
| Recruiting |
NCT03672630 -
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
|
Phase 2/Phase 3 | |
| Completed |
NCT04685720 -
A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients
|
N/A | |
| Terminated |
NCT04553406 -
Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
|
Phase 2 | |
| Recruiting |
NCT05824988 -
Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease
|
||
| Recruiting |
NCT02968212 -
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
|
Phase 2 |